About file location

As the EGA is co-managed by the EMBL-EBI and CRG, files could be located in the UK and/or Spain, as indicated by their respective flags.

Alternatively, files could be located in one of the international Federated EGA nodes, as indicated next to the node's flag.
Need Help?

Germline ALK variant case report

Germline and tumour panel sequencing data from a patient presenting with neurodisability and low-risk neuroblastoma. FASTQ and BAM files available. Germline ALK F1174L variant detected.

Request Access

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

VIVO Biobank Samples Data Access Policy

VIVO Biobank Samples Data Access Policy 1. Introduction This policy governs access to the genomic and phenotypic data from the VIVO Biobank Group studies deposited at the European Genome-phenome Archive (EGA). The data was collected for the purpose of genetic studies on childhood cancers. 2. Data Access Committee (DAC) Access to the data is managed by Newcastle University on behalf of the VIVO Biobank through the VIVO project specific Data Access Committee. Decisions on access are made exclusively based on scientific and ethical criteria in compliance with the original informed consent. 3. Terms of Access To request access, users must: • Be a bona fide researcher affiliated with a recognized research institution. • Provide a brief Research Project Description (max 500 words). • Submit a signed Data Access Agreement (DAA), which is a legally binding contract between the requester's institution and the DAC. 4. Permitted Use Data use is restricted based on the GA4GH Data Use Ontology (DUO) codes assigned to this dataset: • US (user-specific): This data use modifier indicates that use is limited to use by approved users. • Re-identification Prohibited: Requesters must agree not to attempt to re-identify any individual participant. • For additional clinical data, collaboration with members of the DAC is required. 5. Data Security Requirements Users must implement technical safeguards, including: • Storage on secure institutional computer systems behind a firewall. • Encryption of data if stored on portable devices (e.g., USB keys). • Access limited to authorized personnel listed in the DAA. 6. Publication & Acknowledgment Users must acknowledge the VIVO Biobank, members of the DAC, and the EGA in any resulting publications, citing the specific study accession number.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000001885 Cancer Genomics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
i
EGAF50000865020 bai 5.9 MB
EGAF50000865021 bam 2.4 GB
EGAF50000865022 fastq.gz 462.4 MB
EGAF50000865023 fastq.gz 464.1 MB
EGAF50000865024 fastq.gz 447.7 MB
EGAF50000865025 fastq.gz 450.0 MB
EGAF50000865026 fastq.gz 469.5 MB
EGAF50000865027 fastq.gz 471.7 MB
EGAF50000865028 fastq.gz 450.2 MB
EGAF50000865029 fastq.gz 453.7 MB
EGAF50000865030 bai 5.8 MB
EGAF50000865031 bam 1.9 GB
EGAF50000865032 fastq.gz 359.5 MB
EGAF50000865033 fastq.gz 361.1 MB
EGAF50000865034 fastq.gz 346.0 MB
EGAF50000865035 fastq.gz 348.7 MB
EGAF50000865036 fastq.gz 362.6 MB
EGAF50000865037 fastq.gz 365.3 MB
EGAF50000865038 fastq.gz 350.0 MB
EGAF50000865039 fastq.gz 352.7 MB
20 Files (10.8 GB)